Post Views: 103 Share via: Facebook X (Twitter) LinkedIn More Xiaoqiang Guo View All Posts Post navigation Previous Post EHA Reflections | Professor Heng Mei’s Team Reports Landmark LBA Study: BCMA CAR-T–Mediated Immune Reset Opens a New Era of Functional Cure for Refractory ITPNext PostEHA Reflections | Professor Yizhen Li’s Plenary Session Presentation: CD5 Inhibition as a Universal Strategy to Broadly Enhance T-Cell Engager Antitumor Activity